Five new appointments at Elan

Pharmaceutical company Elan has appointed five new members to the company's board of directors.

The three new non-executive board members are Goran Ando MD, Gary Kennedy and Nancy Lurker and the two new executive board members are Shane Cooke and Lars Ekman MD, PhD.

Elan's Chairman of the Board Kyran McLaughlin said: "We are confident they will make valuable contributions to Elan's future success."

Kelly Martin, Elan's CEO added: "These new board directors will increase the board's breadth and depth of experience. Elan's shareholders will be well served by these appointments.'